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Iron, Radiation, and Cancer
by Richard G. Stevens* and Donald R. Kalkwarf*
Increased iron content of cells and tissue may increase the risk of cancer. In particular, high available
iron status may increase the risk of a radiation-induced cancer. There are two possible mechanisms for
this effect: iron can catalyze the production of oxygen radicals, and it may be a limiting nutrient to the
growth anddevelopment ofatransformed cell in vivo. Giventhehighavailable iron content ofthewestern
diet and the fact that the world is changing to the western model, it is important to determine if high
iron increases the risk ofcancer.
Introduction
Iron is the most abundant transition metal in the hu-
man body, and it plays a central role in metabolism.
However, a growing skepticism exists of the conven-
tional wisdom concerning the importance ofiron reple-
tion. A recent editorial in the British Medical Journal
decrying iron deficiency as a scourge of even socially
advantaged populations (1) was followed within months
by an editorial in the samejournal on the benefit ofmild
irondeficiencyinprovidingprotectionfrominfection(2).
The deleterious effects of severe iron deficiency have
been well documented. However, the potential dangers
ofiron excesshavebeenexamined onlyinsofar as severe
iron overload occurs. Given the high available iron con-
tent ofthe western diet and the fact that dietary prac-
tices have been changing throughout the world toward
the western model, the biological consequences ofmod-
erately elevated iron stores deserve attention. Possible
consequences are increased risk of cancer (3,4) and sen-
sitivity to radiation injury.
The purpose ofthis paper is to review the hypothesis
that increased available body iron stores may increase
the risk of cancer and of radiation-induced tumor for-
mation by one or both of two possible mechanisms.
First, excess intracellular iron may increase the am-
bient concentration of oxygen radicals leading to the
depletion of cellular reserves of reducing agents. This
condition ofincreased oxidative stress may thus render
the cell more sensitive to the radicals produced by ion-
izing radiation. Excess intracellular iron may also in-
crease the effective range of radicals produced by ra-
diation. Second, iron may be a limiting nutrient to the
growth and replication of a transformed cell in the hu-
man body, and thus, high iron stores may increase the
chances that a transformed cell will survive to become
a clinically apparent neoplasm.
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An effect ofbody iron stores on sensitivity to radia-
tioninjurywouldhaveimportantimplicationsforsecond
malignant neoplasms arisingfromradiationtherapy; di-
agnostic radiation exposure; occupational radiation and
residentialradonexposures; andexposureofastronauts
and airline crews to cosmic radiation. In all these in-
stances the relative capacity of the host to scavenge
oxygen radicals may influence cancer risk associated
with radiation exposure, and this capacity may be
closely related to iron metabolism. While nutritional
antioxidants have been receiving a great deal ofatten-
tion in this regard, the oxidant iron has received very
little.
Iron and Oxygen Radicals
Oxygenradicalsincludethehydroxylradical, theper-
hydroxyl radical, and their deprotonated forms. They
are highly toxic species produced intracellularly by re-
actions that can be catalyzed by iron. These radicals
have been considered to be some ofthe primary inter-
mediates in the development ofradiobiological damage
(5,6). They have also been implicated in the cellular
activation ofcarcinogens (6), the toxicity ofseveral xe-
nobiotics (7), and the deleterious effects of aging (8).
Oxygen radicals can damage DNA extensively by
strandbreakageanddegradationofdeoxyribose(9), and
may be important in carcinogenesis (10) and other dis-
ease processes (11). Halliwell and Gutteridge (12) dis-
cuss the possible role ofoxygen radicals in a variety of
disease processes and stress the role of iron. Human
phagocytes can cause cytogenetic damage to cultured
cellsinvitro(13), andinappropriate stimulationofphag-
ocytes to produce oxygen radicals may lead to tissue
damage in the whole organism (14).
In tissue at pH 7, the hydroxyl radical exists pre-
dominantly in its protonated form (15), whereas the
perhydroxyl radical exists predominantly in its depro-
tonated form (16) and is called the superoxide radical.
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in vivo; it is removed by dismutation to hydrogen per-
oxide and molecular oxygen. This reaction is catalyzed
by the copper-zinc enzyme, superoxide dismutase
(SOD). Hydrogen peroxide can then react with ferrous
(Fe"2) iron to yield hydroxyl radicals via the Fenton
reaction:
Fe+2 + H202-- Fe+3 + OH- + OH
Transferrincarriesferriciron(Fe+3)intothecellwhere
it can react with superoxide radical to form ferrous iron
plus molecular oxygen. Thus the net reaction is pro-
duction ofhydroxyl radicals inside the cell.
°2 + H202
_ 02 + OH- + OH
When cells are exposed to ionizing radiation, oxygen
radicals such as superoxide and hydroxyl are formed.
The amount of damage caused by the superoxide and
hydroxyl radicals depends on their chances ofdiffusing
to critical tissue sites. Both radicals will react with
themselves to form hydrogen peroxide; but while the
hydroxyl radical will also react rapidly with most bio-
chemical structures (17), the superoxide radicalis more
selective (18). The recombination product, hydrogen
peroxide, is generally even less reactive and can thus
diffusefartherthanthesuperoxideorhydroxylradicals.
Catalase and peroxidases reduce the concentration of
thediffusinghydrogenperoxide inthecellbycatalyzing
its disproportionation.
Catalase
H202 + H202 > 2H20 + 02
Glutathione
peroxidase
2H202 + 2RH2 l> 4H20 + R2
However, ifferrous iron is present,hydrogen peroxide
can be decomposed to reform hydroxyl radicals by the
Fenton reaction. The net effect of ferrous iron is to
increase theprobability thatareactive hydroxylradical
can reach a critical tissue site.
Although neither free ferrous nor ferric ions are
thought to exist in tissue in significant concentrations
iron can exist in avariety ofiron complexes, e.g.,Fe'A
ADP (19,20). These complexes react rapidly with su-
peroxide radical to form ferrous iron. This ferrous iron
isthenavailable forthe Fentonreaction. Grafet al. (20)
analyzed the ability of 12 different iron complexes to
catalyze the Fenton reaction. They found that there is
arequirementforatleast one freeironcoordination site
for the iron complex to successfully produce hydroxyl
radicals from hydrogen peroxide. For example, while
iron complexes ofadenosine di- and triphosphate were
efficient, iron bound to phytate or Desferal (desfemrox-
amine B methanesulfonate) was ineffective.
Although mice administered superoxide dismutase
show decreased radiosensitivity, Marklund et al. (21)
found no correlation of superoxide dismutase activity
and radiosensitivity in seven cancer cell lines. These
authors did find evidence for increased repair ofradia-
tion damage with higher concentrations of glutathione
peroxidases. Indirect evidence for a role ofsuperoxide
dismutase in defense agalnst oxidative damage comes
from the observations ofincreased longevity correlated
with higher SOD activity when comparing many dis-
parate animal (22) and primate species (23).
Iron Distribution
About 60% ofthe 3 to 4 gofiron in ahuman is bound
in hemoglobin (24). The remainder is used in cellular
metabolism or is in storage in the reticuloendothelial
system, spleen, or liver. The distribution ofthis iron is
accomplished by transport oftransfemin in the serum;
it is stored in cells as ferritin (24-26).
Transfemin is the iron transport protein in serum,
and it distributes iron to the cells. It is highly poly-
morphic with variants determined bymultiple alleles at
a single gene locus (27). Transferrin is a glycoprotein
with a molecular weight of about 77,000 and two iron
binding sites (28). It attaches to a transferrin receptor
on the cell surface (29). The transferrin-iron complex is
takenbyendocytosisintothe cell(30,31) wheretheiron
is transferred to other complexing agents. The apo-
transferrmn is ejected from the cell and recycled foruse
(32). The iron atoms cangoto anumberofplacesinside
the cell, includingiron-containingenzymes; ferritin, the
tissue iron-storage protein; or nonspecific iron com-
plexes with, for example, ADP (19,20). Transferrin is
normally about 30% saturated with iron. The more sat-
urated itis, the moreironcomplexesmightbe available
for Fenton reaction.
Excess iron stimulates synthesis of ferritin by the
polyribosomes (33). Ferritin is composed of24 subunits
with a total molecular weight ofapproximately 440,000
(34). Typically, 2500 atoms ofiron are stored inside the
ferritinstructure ashydrousferric-oxide-phosphate mi-
celles(35-37). Thoughtheferricmicellesgrowlikecrys-
tals, the ferritin-iron complex has a relatively uniform
magnetic moment of3.8 Bohr magnetons (horse spleen
ferritin). It is not clear how iron gets into and out of
ferritin (38). It involves an oxidation-reduction with
flavin mononucleotide (39), but what enzymes, if any,
are involved isunknown. Inthe presence ofsuperoxide
radical, theferriciron stored inferritinmaybereduced
to ferrous iron and again be available for the degrada-
tionofhydrogenperoxidetoformhydroxylradicals(40).
The physical chemistry ofthe hydrous ferric phosphate
complex in ferritin (41) will be important in coming to
understand this process.
Whiting et al. (40) showed that chromosome damage
to Chinese hamster ovary cells by ferritin increased in
proportion to its concentration in culture medium, and
Gutteridge et al. (42) reported that ferritin at all levels
of iron loading increased lipid peroxidation of bovine
brain liposomes, particularly in the presence of ascor-
bate. O'Connell et al. (43) examined this further and
found that ascorbate did not enhance the effect offer-
ritin at pH 4.5. In contrast, the iron-binding protein
lactoferrmn inhibits peroxidation of bovine brain lipo-
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somes (44), as does the iron complexing agent, desfer-
rioxamine (45).
Young et al. (46) studied the uptake of radiolabeled
transferrin iron by rat hepatocytes. They found that
about 70%wastakenintoferrtin aftera2hrincubation
with transferrin. Thisresult isin keepingwith the liver
as a primary storage site for iron. A residual iron pool,
possibly bound in iron complexes, increased very rap-
idly at the start of incubation, then declined. The au-
thors estimated the steady-state concentration of the
residual iron pool to be about 23 pg/10,000,000 cells. It
may also be the iron most able to catalyze production
ofradicals. Iron-ADP is particularly effective in react-
ingwithhydrogenperoxidetoformthehydroxylradical
(19,20). Superoxide dismutase, catalase, and glutathi-
one peroxidase all work against the production of the
hydroxyl radical. Iron available forthe Fenton reaction
works for the production ofthat radical.
Mechanisms of Radiosensitization
Chemical modification of radiation sensitivity has
been ofkeen interest to clinicians for many years (47).
Hypoxiccells areradioresistant, andhyperbaricoxygen
has been used to increase the effectiveness ofradiation
in treatment of cancer. Chemical agents that might
mimic the effects of oxygen have been introduced and
used with varying degrees of success. This class of
agents is electron-affinic, and well-known examples in-
clude misonidazole and metronidazol. These and anum-
ber of other newly synthesized hypoxic cell radio-
sensitizers are themselves capable of transforming
C3H1OT1/2 cells in vitro (48). The transformation is
inhibitedbysuperoxidedismutase, suggestingthatpro-
ductionofoxygenradicals accountsforatleast aportion
ofthe effect ofthese drugs both as radiosensitizers and
transformers. A variety of new radiosensitizing drugs
are being tested (49), and metal complexes that bind to
DNA are also being examined (50). The radiosensitizer
RSU-1069 binds to DNA possibly at phosphate groups
(51). The tumor promoter TPA has also been shown to
increase transformation of C3H1OT1/2 cells by gamma
rays (52).
Greenstock and Whitehouse (53) studied the reaction
mechanism of electron-affinic radiosensitizers and de-
scribed a model in which the sensitizers irreversibly
affixradiationdamageincriticalmoleculessuchasDNA
by further oxidizing radical sites on those molecules
formed by attack ofoxygen radicals. In the absence of
sensitizer, much of this damage would be repaired by
natural cellular reducing agents. Oxygen added 5 msec
after irradiation ofhypoxic cells does not radiosensitize
them (54); this is consistent with the view that rapid
reactions are involved in sensitization. Greenstock and
Whitehouse (53) state "Sensitizerefficacyisdetermined
bytheabilitytooxidizetheradiationtargetandisfound
to increase exponentially withincreasing electron affin-
ity." They also concluded that the sugar-phosphate
backbone of DNA is the primary site of damage, not
the purine and pyrimidine bases.
Thioldepletioncanhavearadiosensitizingeffect(55-
57), whereas exogenous glutathione (58) and otherami-
nothiols (59) can act as radioprotectors. Buthionine sul-
foximine inhibits the enzyme gamma-glutamylcysteine
synthetase and leads to the rapid depletion ofreduced
glutathione (55). Cells are viable and apparently oth-
erwise unaffected at exposure to concentrations suffi-
cient to deplete glutathione. Glutathione-depleted V79-
379A cells (a Chinese hamster fibroblast line) were ra-
diosensitized at all oxygen tensions examined though
the effect was least in air and greatest in anoxia (55).
Radiosensitization of hypoxic cells by misonidazole is
enhanced by glutathione depletion (55,60,61). Bump et
al. (62) conclude that "Ingeneral, radiosensitization [by
glutathione oxidizing agents] correlates with the rate
ofreactionwithcellularreducingagentsandoccursonly
when the reductive capacity of the cell is exceeded."
Glutathione depletion radiosensitizes even when in-
duced after irradiation consistent with a role for glu-
tathione in radiation damage repair (62). There may be
important differences in the cross-link repair process
between cycling and noncycling tumor cells (63), and
oxygenation oftumor tissue affects cell turnover.
Calcium homeostasis is important in maintenance of
cellular reducing agents, in particular glutathione (64).
Smithetal. (65)foundthatincubationoffreshlyisolated
hepatocytes in calcium-free mediagreatlyincreasedthe
toxicity of carbon tetrachloride, bromobenzene, and
ethyl methanesulfonate. Reed and Fariss (64) specu-
lated that calcium efflux led to depletion ofglutathione
and consequently greater susceptibility to oxidative
damage by the hepatotoxins.
There is evidence that electromagnetic radiation can
affect calcium homeostasis at certain combinations of
frequency and intensity (66-68). This leads to the in-
triguing possibility that nonionizing radiation may, un-
der certain circumstances, act as a radiosensitizer and
that exposure to nonionizing radiation might increase
toxicity ofcarbon tetrachloride to hepatocytes invitro.
So-called window effects ofnonionizing radiation on fi-
broblast protein synthesis (69) and photochemical re-
actions (70) have been reported. There is also a report
that a 2.45 GHz microwave affects mouse-embryo fi-
broblast transfornation by X-ray and phorbol ester
(71).
One oftheimportantlate effects ofradiationis onthe
bone marrow (72). Leukemia, and in particular acute
nonlymphocytic leukemia, isstronglyrelatedtoionizing
radiation exposure (73,74). The high concentration of
iron in the marrow may account, in part, for the high
radiation sensitivity of hemopoietic tissue. Since non-
lymphocytes such as neutrophils and macrophages gen-
erate oxygen radicals during normal functioning (9,75),
nonlymphocytes may rely more heavily on cellular re-
ducing agents and maybe at greaterradiation sensitiv-
ity than lymphocytes. The evidence is not adequate to
determine whetherelectromagneticfieldsinfluencerisk
ofleukemia, but this has been suggested from occupa-
tional studies (76), and again nonlymphocytic leukemia
has been cited as the cancer most strongly associated
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with exposure in adults. However, a small study ofres-
idential exposure to electric and magnetic fields failed
to provide support for the hypothesis (77). Age at ex-
posure to either ionizing ornonionizing radiation would
be expected to be important since the baseline risk of
lymphocytic and nonlymphocytic leukemias changes
greatly with age (78).
Radiationleukemogenesisis, nodoubt, verycomplex.
The interaction of chemicals and irradiation in T-cell
leukemogenesis depends on the dose ofeach (79). Other
factors such as marrow iron concentration and calcium
homeostasis may also be involved.
Certain cancer therapeutic drugs such as mitomycin
C apparently produce oxygen radicals, yet are not ra-
diosensitizers (80). However, the differential toxicity of
mitomycin C is greatest to hypoxic cells at low concen-
trations. Calculations based on the electron affinity of
the drug show that detectable radiosensitization would
require concentrations far in excess ofthose tested and
that they would be highly cytotoxic (80).
Radiosensitizers such as paraquat are thought to in-
crease the DNA damaging capability ofionizing radia-
tionbyvirtue ofthe additionalproductionofsuperoxide
radicalthatleadstothedepletionofreducedglutathione
(81). Reduced glutathione is necessary for the activity
ofthe seleno-enzyme glutathione peroxidase that scav-
enges peroxides and thereby works against hydroxyl
radical formation (82). Since the principal mechanism
bywhich ionizingradiation damages DNAisthought to
bebythehydrolysis ofwatertoproduce oxygenradicals
(83,84), iron-catalyzed oxygen radicals may sensitize a
cell to radiation damage by depletingthe cell ofits rad-
ical scavenging capabilities. This would be analogous to
the mechanism by which paraquat acts as a radiosen-
sitizer. Such a cell would then be more susceptible to
radiation damage. Teicher et al. (85) provided evidence
that certain cyclopentadienyl complexes of cobalt and
iron are radiosensitizers of hypoxic EMT6 cells. The
possible mechanisms for this effect discussed included
metalbindingtoDNAandincreasedoxidativecleavage.
Bleomycin is a cancer therapeutic drug that cleaves
DNA. Its action is dependent on ferrous iron and ox-
ygen, and it is believed that production ofoxygen rad-
icals atthe DNAmolecules accountsforitsefficacy(86).
Hoffmann et al. (87) examined differences in sensitivity
to DNA strand breaks by exposure to hydrogen per-
oxide. They found that a given amount of hydrogen
peroxide produced 5 to 10 times more strand breaks in
human DNA than in hamster DNA, and 2 to 4 times
more in mouse DNA. The ability to scavenge hydrogen
peroxide was similar. They hypothesized that differ-
encesinchromatin-boundironaccountedforthespecies-
specific sensitivity, although they did not measure iron
content in the cells.
Willson (88,89) has discussed the importance of iron
inradiation-induced injury aswell asinpotentialeffects
in treatment of cancer with radiation. He has also
stressed the possible importance ofzinc in the safe se-
questration ofintracellular iron; low zinc may increase
the danger that iron will catalyze radical production.
Hydrogen Peroxide
Ito et al. (90) reported that oral administration of
hydrogen peroxide to mice induced hyperplasia and
stomach cancer. Theylaterreported (91)thattherewas
a strong negative correlation of tissue damage by hy-
drogen peroxide and catalase activity of the mouse.
Ionicironoriron-saturatedferritineffectivelycatalyzes
the production ofhydroxyl radicals from hydrogen per-
oxide (92), and this was significantly inhibited by apo-
transferrin in the cell-free system used by the authors.
It should be noted that the method of implicating the
hydroxyl radical must be chosen with care as certain
assaysmaythemselvesaltertheyieldoftheradical(93).
Ward etal. (94) providedevidencethatdouble-strand
breaks in DNA are required to cause cell death. They
usedhydrogen peroxide at0°C toproduce single-strand
breaks and asserted that these breaks resulted from a
metal catalyzed oxidation of the hydrogen peroxide to
the hydroxyl radical. At the cold temperature, the re-
duction offerricbacktoferrouswas slow, andthus only
one molecule at a time could cause damage. At 37°C,
hydrogen peroxide was much more lethal. The authors
suggest a mechanism whereby hydrogen peroxide dif-
fuses to DNA where it can be oxidized by a DNA-fer-
rous iron adduct to a hydroxyl radical (95); the ferric
iron can be reduced once again to ferrous by another
hydrogenperoxidemolecule, andthenreactwithathird
to produce a double strand break and cell death. Spitz
et al. (96) showedthathydrogen peroxideresistantvar-
iants ofChinese hamster fibroblasts had increased cat-
alase activity.
Imlay and Linn (97) have studied the effects ofDNA-
bound iron on the formation of hydroxyl radicals from
hydrogen peroxide and the influence ofNADH and re-
pair enzymes on the toxicity of these reactions. These
reactions are efficient enough to suggest a new tech-
nology for DNA cleavage. Iron adducts ofEDTA were
used to bind to DNA and cleave at sequence-specific
sites nonenzymatically by exploiting Fenton chemistry
(98).
Halliwell and Gutteridge (12,99) have suggested that
hydrogen peroxide may be a particularly dangerous
molecule due to the fact that it is not highly reactive
itself, and it is nonpolar and can diffuse through cell
membranes. Ifproduced in the cytoplasm, it may then
diffuse to nuclear DNA where, ifa DNA-iron adduct is
encountered, it can be readily oxidized to the hydroxyl
radical. Many of the dangerous products of radiation
hydrolysis of water in the cell may use themselves up
rapidly. Since radiationkillingis primarilythe result of
DNA damage (100,101), hydrogen peroxide, though
mild-mannered itself, may serve to preserve a portion
ofthe radiation insult long enough for it to do its max-
imal damage directly at the DNA molecule.
Adams andJameson (54) and Chapman and Gillespie
(100) discuss three periods in the time course ofradia-
tioneffects. Thefirstisthephysicalperiodduringwhich
primary interactions of fast electrons or high energy
photons with cellular atoms occur. The second is the
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chemical period during which secondary interactions of
resulting ions (e.g., hydrated electrons) with cellular
molecules occur. These reactions are virtually complete
within one second of irradiation. The chemical period
continues through secondary biochemical reactions for
up to hours. Diffusion of hydrogen peroxide to DNA-
ironadductsitesmayoccurduringthisperiod. Thethird
period is the biological, during which long-term conse-
quences such as cancer are experienced. There is also
evidence for two different time periods for radiation
damage repair processes in eukaryotic cells (102).
Thus, increased available ironmayincrease oxidative
damage tocellsinthe absence ofradiationexposure and
may also increase the damaging capability ofradiation
in two ways: react with radicals produced by radiation
to increase their tissue reactivity and effective range,
and increase oxidative stress and deplete the cell ofits
radical-scavenging capabilities.
Iron As Limiting Nutrient
There is another mechanism by which iron level may
influence development of clinically apparent cancer.
Ironmaybe alimitingnutrientinhumanstothegrowth
and replication ofinvading pathogenic microorganisms.
By analogy, successful establishment of a malignant
clone from one or a few transformed cells may depend
on the availability of iron. Three lines of evidence for
this idea are discussed by Weinberg (103). First, bac-
teriostatic effects ofconalbumin in egg white, lactofer-
rin in milk, and transferrin in human serum were all
shown to be the result oftheir avidity for iron. Second,
the human body's response to bacterial invasion or can-
cer often incudes several mechanisms that could reduce
the availability of iron: intestinal iron assimilation is
restricted, plasma iron level decreases, and fever de-
velops. Third, avariety ofepidemiological observations
are consistent with the notion that reduced iron level
plays a role in defense against infection.
Weinberg(103) hasdeveloped theargumentthatneo-
plastic cells may behave like invading microorganisms
with regard to iron needs and acquisition. There is evi-
dencethatneoplastic cellshavealteredtransferrinbind-
ing capability and that they may produce other iron-
binding polypeptides that may enhance growth in iron-
restricted environments (104). There are similarities in
the host response to invading microorganisms and to
neoplastic cellgrowth. Inaddition, neoplasticcellshave
been found to be killed by heating at temperatures 1 to
1.5 degrees less than their nonnal counterparts (105).
This effecthasformedthe basis forhyperthermiatreat-
ment ofcancer(106) and mayresult from affects on iron
acquisition (107).
Konopka and Neilands (108) found that human serum
albumin reduces the ability of certain bacterial sider-
ophorestobindiron. Theseauthorsconcludedthatthese
results indicate that serum albumin may act synergist-
ically with other factors in the serum, such as trans-
ferrin, to limit iron supply and in this way restrict the
growth of invading microorganisms. Ifalbumin can af-
fect iron acquisition by transformed cells in a similar
manner, then low albumin might be associated with in-
creased risk ofcancer. This was found to be the case in
a study of Chinese government workers (3) and in a
study ofthe U.S. adult population (4).
Bergeron et al. (109) injected a leukemia cell line,
L1210, in two groups ofmice. One group received iron
dextraninjections andtheotheriron-free dextran. Both
groups were fed nonpurified Rodent Lab Chow from
Ralston Purina. The group receiving iron died sooner
and had greater tumor burden of cells (peritoneal har-
vest prior to death). The authors concluded that their
results were consistent with the hypothesis that iron
may be a limiting nutrient to the growth of a cancer
cell. Hann et al. (110) induced iron deficiency in three
strains of mice through dietary restriction and found
thattransplanted colonadenocarcinoma, hepatoma, and
mammary adenocarcinoma cells grew more slowly in
these iron deficient mice than in normal controls.
Cavanaugh et al. (111) found that the bacterial iron
chelators Parabactin and Compound II inhibited the
growth of L1210 cells in culture, and they concluded
that the mechanism involved inhibition ofthe iron-con-
taining enzyme, ribonucleotide reductase, and conse-
quently DNA synthesis. Basset et al. (112) reported
that in addition to blocked DNA synthesis, iron chela-
tionbydesferrioxamine alsoblocked othersystemscrit-
ical for cell growth.
A surface receptor for transferrin on malignant cells
has been identified (113,114). This receptor segregates
withmalignantbehaviorinsomaticcellhybridsbetween
normal and malignant cells. A monoclonal antibody to
the transferrin receptor stops growth of a T leukemia
cell line in vitro (114), and the mechanism is thought to
be by restricting iron uptake by the cell (115). Mono-
clonal antibodies can also inhibit the normal growth of
erythroid bursts (116). Increased transferrin receptor
concentration may confer an important growth advan-
tage to malignant cells in an iron restricted host envi-
ronment. Transferrin receptors are expressed in de-
tectable amounts onnormaldividingcells andoncertain
differentiated cells as well (117), and they are found in
greater numbers on immature murine erythroid cells
than on mature cells (118).
It must be noted that in workers exposed to pluton-
ium, high iron stores might serve to reduce the risk of
plutonium absorption. Plutonium binds to ferritin and
transferrin and when iron stores are high, plutonium
absorption is lowest (119,120).
Diet and Iron Status in Humans
Severe iron-deficient dietleads toirondeficiency ane-
mia, and severe iron-overloaded diet can lead to iron-
overload (121). Within the normal range ofiron intake,
however, the relationship between intake and iron
stores is unclear. Human iron exchange is restricted to
about 10%/year (122), and typically much less than 10%
of ingested iron is absorbed (26). Serum ferritin level
is thought to be the best single indicator ofiron stores
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in otherwise healthy individuals,and it varies widely in
the population (123). The mean concentration is higher
in men than in women (124). However, the First Na-
tional Health and Nutrition Examination Survey con-
cluded that the prevalence of anemia was not closely
related todietaryironintakeinthe United States (125).
Evidence that intake does affect iron status is pro-
vided by a study in Africa oftwo closely related groups
ofone Turkana tribe (126). The diets ofthe two groups
were similar in total calories, but one group consumed
fish and milk, whereas the other consumed primarily
milk and thus had lower available iron intake. The two
groups were very similar in height, weight, and age.
The fish eaters, however, had hemoglobin of12.7 g/dL,
transferrin saturation of 26%, and serum iron of 59.7
,ug/dL, whereas the milk drinkers had values of 11.6,
14and38.2, respectively. Lowerironintakeledtolower
ironstores. Conversely, Olssonetal. (127)reportedthat
in Sweden where food has been iron fortified for over
30years, therewasanunusuallyhighprevalenceofhigh
serum iron and early stage hemochromatosis in men.
Inorganic Iron
Inorganic iron salts have not been found to be re-
markableintransformationorcarcinogenesis (128-130).
Stokinger (131) concluded that there is little evidence
for an increased cancer risk in humans exposed to iron-
oxide (in mining, for example). However, Turver and
Brown (132) have shown that iron found in asbestos
fibers cangenerate oxygenradicalsandinducelipidper-
oxidation and DNA-strand breaks in C3H1OT1/2 cells.
Desferrioxamine inhibited the damage. They concluded
that iron-catalyzed damage may play an important role
in asbestos pathogenicity in humans. Weinberg (133)
has hypothesized that the difference in the carcinogen-
icity between amphibole asbestos (high cancer risk and
high iron content) and serpentine asbestos (low cancer
risk and low iron content) can be explained by the iron
content ofthese respective silicates.
Much currentresearch on diet and cancerhasfocused
ontheprotective effectsofsuchnutrientsastocopherol,
carotenoids, selenium, and ascorbic acid (134-137).
While each undoubtedly has many effects on cellular
metabolism, they share the fact that they are all an-
tioxidants. Thus, iron may catalyze the production of
proximate carcinogens (oxygenradicals)whilethese an-
tioxidants may destroy them. In a recent review article
Cerutti (138) discusses the evidence for an effect of
prooxidants on increased cancer risk. The prooxidant
states (e.g., hyperbaric oxygen tension, radiation, fer-
rous iron) are mediated through the production of ox-
ygen radicals, in particular the hydroxyl radical. Uric
acid has been suggested as another antioxidant defense
mechanism and has been shown to bind ferric iron in
such awayas toinhibitits oxidationby ascorbate (139).
Stocker and Ames (140) have also suggested that bili-
rubin and copper are important to consider as antioxi-
dants. Iron binding by phytate has been argued to ac-
count for a reduced colon cancer risk for those
consuming a high fiber diet (141).
Conclusions
The two broad mechanisms by which iron may in-
crease risk of cancer or of radiation-induced transfor-
mation are depicted in Figure 1. Iron may increase ox-
idative stress to a cell and thereby the risk of
transfonnation. And iron availability may influence the
chances that a cancer cell will survive. These possibil-
ities could be tested by controlled experiments. Radia-
tion exposures of cells from the same strain but with
different iron contents may show whether or not the
iron content in the cells had an effect on theirradiation-
induced mutation or death.
Although the definitivelaboratoryexperiments await
execution, four epidemiological studies have been done
that are consistent with the hypothesis that high iron
storesareassociatedwithincreasedriskofgeneralmor-
tality and of cancer. Sera were tested from two popu-
lations for ferritin and transferrin. Ferritin was higher
and transferrin was lower in Solomon Islanders who
subsequently died over a 10-year period (142) and in
Chinese government workers who developed cancer (3)
than in suitably chosen controls. Selby and Friedman
(143) reported a reduced lung cancer risk associated
with anemia and with high total iron binding capacity
of serum in women in the Kaiser-Permanente Medical
PlaninCalifornia. Stevensetal. (4)reportedthatcancer
riskwas higherinmenwith evidence ofhigh iron stores
in the United States. Four sites appeared strongly re-
lated: lung, colon, bladder, and esophagus. Onthe basis
of the idea that iron may be a limiting nutrient to in-
vading pathogens and cancer cells (103), Weinberg and
Weinberg (144) suggested giving blood as possibly re-
ducing risk of disease. This is being tested in a popu-
lation ofblood donors.
According to the schema proposed in this paper, ex-
cess iron itselfmight increase cancer risk. In addition,
iron elevated short of a level that would by itself in-
crease cancer risk, might nonetheless act as a radi-
osensitizer by virtue ofthe mechanisms previously de-
scribed. Very few experiments have been perfonned
that have addressed directly this iron hypothesis. Ra-
Iron as
"carcinogen"
- ______ _t..® ---------_
Normal cell Cancercell
o + HO 2 22 2 2
Fe ,"
*OH
Iron as
"food"
CANCER
@e' +
Fe
Fe
FIGURE 1. Two mechanisms by which iron may increase cancer or
radiation-induced transformation.
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diation transformation experiments in which antioxi-
dants have been tested as protectors (59,136) could eas-
ily be modified to deternine if transferrin-iron or
ferritin-iron complexes addedtothegrowthmediumact
to increase the effectiveness of radiation. In addition,
the protocol of Skov (84) in which the mechanisms by
which the radiosensitizers misonidazole and 2,2,6,6-te-
tramethyl-1,4-piperidone-N-oxyl enhance radiation-in-
duced DNA damage could be modified to examine the
effects oforganic iron (bound to ferritin, transferrin, or
ADP). A mouse leukemogenesis experiment in which
dietary anemia is induced in one group, iron excess by
injection is induced in anothergroup, and anormal iron
level is maintained in a third group would address di-
rectly the hypothesis that iron level affects the tumor
burden after a specified radiation dose.
Increased cancer risk has been associated with
screening, diagnostic, ortherapeuticradiationexposure
to certain human populations: those given radiation
therapy for a first cancer (145-147), women exposed to
mammographic screening (148), those given Thorotrast
(149) and radium (150) patients, and radiation-treated
ankylosing spondylitics (151). It is the thesis of this
paper that the iron status of the exposed individuals
may be one ofthe factors determining level ofrisk: the
higher the iron stores, the higher the risk.
In addition to affecting risk ofcancer, iron nutriture
may be implicated in prognosis after cancer diagnosis
and in the site ofdistant metastases. A malignant neo-
plasm must acquire iron in order to thrive, therefore
clinical manipulations ofiron status may be of value in
management ofcancer patients. In addition, the higher
iron level ofa tissue, the greater may be the chance it
will be the site of a metastasis; the liver is a common
metastatic site and is iron-rich.
Iron-deficiency anemia is a serious problem world-
wide, and iron repletion has been a primary goal of
nutritional programs. Possibly for this reason, physio-
logical variation in iron availability has not received
scrutiny as apossible carcinogen orradiosensitizer. Ex-
cess iron over a minimum necessary to avoid anemia
mayinfacthaveadverselong-termhealthconsequences
including an increase in cancer risk and increased sus-
ceptibility to radiation-induced cancer.
ThisworkwassupportedbytheOfficeofHealthandEnvironmental
Research of the U.S. Department of Energy under contract DE-
AC06-76RLO-1830.
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